Lantern Pharma Inc. (LTRN)

3.71

-0.24 (-6.08%)

At close: Mar 03, 2025, 3:59 PM

3.55

-4.37%

After-hours: Mar 03, 2025, 05:46 PM EST

Lantern Pharma Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-15.96M	-14.26M	-12.36M	-5.91M	-2.43M	-1.73M
Depreciation & Amortization	14.62K	10.08K	6.76K	3.39K	1.63K	-2.54K
Stock-Based Compensation	1.07M	1.19M	961.54K	1.19M	117.76K	185.6K
Other Working Capital	538.02K	-1.03M	-950.47K	-1.06M	-191.79K	271.84K
Other Non-Cash Items	-5.17K	906.49K	90.66K	1.08M	-251.65K	-76.32K
Deferred Income Tax	n/a	n/a	112.56K	-1.08M	251.65K	n/a
Change in Working Capital	538.02K	-611.86K	599.96K	-939.06K	180.88K	271.84K
Operating Cash Flow	-14.35M	-12.77M	-10.59M	-5.65M	-2.13M	-1.27M
Capital Expenditures	-18.73K	-27.84K	-15.5K	-16.14K	-5.72K	n/a
Acquisitions	n/a	-179.27M	19.53B	n/a	n/a	5.34K
Purchase of Investments	-8.2M	-3.91M	-19.58M	n/a	n/a	n/a
Sales Maturities Of Investments	7.28M	4.12M	64.09K	n/a	n/a	n/a
Other Investing Acitivies	-1	179.27M	-19.53B	-5.72M	n/a	5.34K
Investing Cash Flow	-930.21K	179.27K	-19.53M	-16.14K	-5.72K	5.34K
Debt Repayment	n/a	n/a	n/a	108.5K	n/a	n/a
Common Stock Repurchased	-500K	-2.48M	-939.67K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-2.48M	-5.58M	26.25M	2.92M	535K
Financial Cash Flow	-500K	-2.18K	63.42M	23.66M	2.92M	535K
Net Cash Flow	-15.81M	-14.78M	33.3M	18M	786.87K	-731.18K
Free Cash Flow	-14.37M	-12.8M	-10.61M	-5.67M	-2.13M	-1.27M